6min chapter

Diabetes Core Update cover image

Diabetes Core Update – March 2023

Diabetes Core Update

CHAPTER

Diabetes Care - Is This a Safety Measure?

Golimomab is a monoclonal antibody that goes against TNF-alpha, tumor necrosis factor. It gets in the way of lymphocyte activation and destruction of beta cells. The Tiger trial showed both during the time that this was given as well as for a year afterwards, this concept worked. Our next article is on an important and disturbing topic, which is youth onset diabetes.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode